Xavier Espanel

773 total citations
18 papers, 641 citations indexed

About

Xavier Espanel is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xavier Espanel has authored 18 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Xavier Espanel's work include Protein Tyrosine Phosphatases (8 papers), Galectins and Cancer Biology (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Xavier Espanel is often cited by papers focused on Protein Tyrosine Phosphatases (8 papers), Galectins and Cancer Biology (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Xavier Espanel collaborates with scholars based in United States, France and Germany. Xavier Espanel's co-authors include Marius Sudol, Rob Hooft van Huijsduijnen, Sébastien Wälchli, Alex Chang, Mark T. Bedford, Stacey Rentschler, Axel Harrenga, Gilbert Brun, Germain Gillet and Gianni Cesareni and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Xavier Espanel

18 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xavier Espanel United States	13	546	142	132	99	49	18	641
Thomas M. Beres United States	8	669 1.2×	78 0.5×	97 0.7×	178 1.8×	102 2.1×	11	827
Adele Casamassima United Kingdom	10	395 0.7×	160 1.1×	59 0.4×	42 0.4×	41 0.8×	10	519
Jessica B. Casaletto United States	6	311 0.6×	144 1.0×	118 0.9×	43 0.4×	37 0.8×	7	498
Constance M. Ely United States	8	349 0.6×	85 0.6×	76 0.6×	55 0.6×	71 1.4×	10	449
Sarla G. Aneja United States	6	410 0.8×	137 1.0×	53 0.4×	90 0.9×	21 0.4×	7	534
Iwona Pilecka Poland	11	329 0.6×	215 1.5×	73 0.6×	77 0.8×	41 0.8×	11	508
Susan Adams United States	8	313 0.6×	55 0.4×	108 0.8×	213 2.2×	31 0.6×	10	593
Ana Merino‐Trigo Spain	8	235 0.4×	120 0.8×	56 0.4×	76 0.8×	29 0.6×	13	419
Fruma Yehiely United States	15	766 1.4×	65 0.5×	157 1.2×	131 1.3×	67 1.4×	20	928
Jill M. Shirokawa United States	10	522 1.0×	72 0.5×	139 1.1×	40 0.4×	96 2.0×	11	668

Countries citing papers authored by Xavier Espanel

Since Specialization

Citations

This map shows the geographic impact of Xavier Espanel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Espanel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Espanel more than expected).

Fields of papers citing papers by Xavier Espanel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Espanel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Espanel. The network helps show where Xavier Espanel may publish in the future.

Co-authorship network of co-authors of Xavier Espanel

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Espanel. A scholar is included among the top collaborators of Xavier Espanel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Espanel. Xavier Espanel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wälchli, Sébastien, Xavier Espanel, & Rob Hooft van Huijsduijnen. (2005). Sap-1/PTPRH activity is regulated by reversible dimerization. Biochemical and Biophysical Research Communications. 331(2). 497–502. 28 indexed citations

Espanel, Xavier, et al.. (2004). Applying the SPOT peptide synthesis procedure to the study of protein tyrosine phosphatase substrate specificity: probing for the heavenly match in vitro. Methods. 35(1). 64–72. 28 indexed citations

Espanel, Xavier, Nicholas E. Navin, Yusuke Kato, Masaru Tanokura, & Marius Sudol. (2003). Probing WW Domains to Uncover and Refine Determinants of Specificity in Ligand Recognition. Cytotechnology. 43(1-3). 105–111. 4 indexed citations

Pasquali, Christian, Sébastien Wälchli, Xavier Espanel, et al.. (2003). Identification of Protein Tyrosine Phosphatases with Specificity for the Ligand-Activated Growth Hormone Receptor. Molecular Endocrinology. 17(11). 2228–2239. 47 indexed citations

Espanel, Xavier, et al.. (2003). Mapping of Synergistic Components of Weakly Interacting Protein-Protein Motifs Using Arrays of Paired Peptides. Journal of Biological Chemistry. 278(17). 15162–15167. 34 indexed citations

Wälchli, Sébastien, Xavier Espanel, Axel Harrenga, et al.. (2003). Probing Protein-tyrosine Phosphatase Substrate Specificity Using a Phosphotyrosine-containing Phage Library. Journal of Biological Chemistry. 279(1). 311–318. 43 indexed citations

Espanel, Xavier, et al.. (2002). The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities. Protein Science. 11(10). 2326–2334. 33 indexed citations

Espanel, Xavier, et al.. (2001). Pulling Strings Below the Surface: Hormone Receptor Signaling Through Inhibition of Protein Tyrosine Phosphatases. Endocrine. 15(1). 19–28. 17 indexed citations

Espanel, Xavier & Marius Sudol. (2001). Yes-associated Protein and p53-binding Protein-2 Interact through Their WW and SH3 Domains. Journal of Biological Chemistry. 276(17). 14514–14523. 113 indexed citations

10.

Espanel, Xavier, et al.. (2001). Pulling Strings Below the Surface: Hormone Receptor Signaling Through Inhibition of Protein Tyrosine Phosphatases. Endocrine. 15(1S). S19–S28. 2 indexed citations

11.

Chang, Alex, et al.. (2000). Rsp5 WW Domains Interact Directly with the Carboxyl-terminal Domain of RNA Polymerase II. Journal of Biological Chemistry. 275(27). 20562–20571. 66 indexed citations

12.

North, Sophie, Xavier Espanel, Frédéric Bantignies, et al.. (1999). Regulation of cdc2 gene expression by the upstream stimulatory factors (USFs). Oncogene. 18(11). 1945–1955. 28 indexed citations

13.

Rentschler, Stacey, et al.. (1999). The WW Domain of Dystrophin Requires EF-Hands Region to Interact with β-Dystroglycan. Biological Chemistry. 380(4). 431–42. 100 indexed citations

14.

Espanel, Xavier & Marius Sudol. (1999). A Single Point Mutation in a Group I WW Domain Shifts Its Specificity to That of Group II WW Domains. Journal of Biological Chemistry. 274(24). 17284–17289. 57 indexed citations

15.

Espanel, Xavier, Laurent Le Cam, Sophie North, et al.. (1998). Regulation of E2F-1 gene expression in avian cells. Oncogene. 17(5). 585–594. 7 indexed citations

16.

Kästner, Anne, Xavier Espanel, & Gilbert Brun. (1998). Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.. PubMed. 9(10). 857–67. 15 indexed citations

17.

Espanel, Xavier, Anne Kästner, Olivier Stettler, et al.. (1997). p34(cdc2) and mitotic cyclin expression in the developing quail neuroretina. The International Journal of Developmental Biology. 41(3). 469–476. 12 indexed citations

18.

North, Susan L., Xavier Espanel, Bertrand Tavitian, Guillaume Brun, & Germain Gillet. (1996). Two distinct regulatory elements control quail cdc2 transcription: possible involvement in the control of retinoblast differentiation.. PubMed. 7(3). 339–49. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact